SHAREHOLDERS’ EQUITY (Tables)
|
12 Months Ended |
Oct. 31, 2022 |
|---|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| SCHEDULE OF OPTION ACTIVITY |
Information
regarding the Non-Plan Options for the two years ended October 31, 2022 is as follows:
SCHEDULE
OF OPTION ACTIVITY
| |
|
Shares |
|
|
Weighted
Average Exercise
Price Per Share |
|
| Options Outstanding at October 31, 2020 |
|
|
1,698,000 |
|
|
$ |
2.58 |
|
| Exercised |
|
|
(56,000 |
) |
|
$ |
2.58 |
|
| Options Outstanding October 31, 2021 |
|
|
1,642,000 |
|
|
$ |
2.58 |
|
| Exercised |
|
|
(1,642,000 |
) |
|
$ |
2.58 |
|
| Options Outstanding and Exercisable at October 31, 2022 |
|
|
- |
|
|
|
|
|
|
| SCHEDULE OF WARRANTS ACTIVITY |
Information
regarding the Company’s warrants for the two years ended October 31, 2022 is as follows:
SCHEDULE
OF WARRANTS ACTIVITY
| |
|
Shares |
|
|
Weighted
Average Exercise
Price Per Share |
|
|
Aggregate
Intrinsic Value
|
|
| |
|
|
|
|
|
|
|
|
|
| Warrants Outstanding at October 31, 2020 |
|
|
560,000 |
|
|
$ |
4.71 |
|
|
|
|
|
| Issued |
|
|
300,000 |
|
|
$ |
6.56 |
|
|
|
|
|
| Warrants Outstanding at October 31, 2021 |
|
|
860,000 |
|
|
$ |
5.36 |
|
|
|
|
|
| Issued |
|
|
60,000 |
|
|
$ |
4.77 |
|
|
|
|
|
| Exercised |
|
|
(60,000 |
) |
|
$ |
2.06 |
|
|
|
|
|
| Expired |
|
|
(560,000 |
) |
|
$ |
4.71 |
|
|
|
|
|
Warrants Outstanding and Exercisable at
October 31, 2022 |
|
|
300,000 |
|
|
$ |
6.56 |
|
|
$ |
0 |
|
|
| Two Thousand Ten Plan [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| SCHEDULE OF OPTION ACTIVITY |
SCHEDULE
OF OPTION ACTIVITY
| |
|
Shares |
|
|
Weighted
Average Exercise
Price Per Share |
|
|
Aggregate Intrinsic Value |
|
| |
|
|
|
|
|
|
|
|
|
| Options Outstanding at October 31, 2020 |
|
|
1,907,534 |
|
|
$ |
2.82 |
|
|
|
|
|
| Exercised |
|
|
(178,500 |
) |
|
$ |
2.75 |
|
|
|
|
|
| Expired |
|
|
(10,400 |
) |
|
$ |
4.57 |
|
|
|
|
|
| Options Outstanding at October 31, 2021 |
|
|
1,718,634 |
|
|
$ |
2.82 |
|
|
|
|
|
| Exercised |
|
|
(212,000 |
) |
|
$ |
2.68 |
|
|
|
|
|
| Expired |
|
|
(5,134 |
) |
|
$ |
3.63 |
|
|
|
|
|
Options Outstanding and Exercisable at
October 31, 2022 |
|
|
1,501,500 |
|
|
$ |
2.83 |
|
|
$ |
4,156,000 |
|
|
| SCHEDULE OF OUTSTANDING AND EXERCISABLE |
The
following table summarizes information about stock options outstanding under the 2010 Share Plan as of October 31, 2022:
SCHEDULE
OF OUTSTANDING AND EXERCISABLE
|
Range of Exercise
Prices
|
|
|
Number Outstanding and Exercisable
|
|
|
Weighted Average Remaining Contractual Life (in
years)
|
|
|
Weighted Average Exercise
Price
|
|
| $ |
0.67 - $2.27 |
|
|
|
477,500 |
|
|
|
3.78 |
|
|
$ |
1.46 |
|
| $ |
2.58
- $3.13 |
|
|
|
515,000 |
|
|
|
2.38 |
|
|
$ |
2.78 |
|
| $ |
3.46 - $5.30 |
|
|
|
509,000 |
|
|
|
5.54 |
|
|
$ |
4.17 |
|
|
| 2018 Plan [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| SCHEDULE OF OPTION ACTIVITY |
SCHEDULE
OF OPTION ACTIVITY
| |
|
Shares |
|
|
Weighted
Average Exercise
Price Per Share |
|
|
Aggregate Intrinsic Value |
|
| |
|
|
|
|
|
|
|
|
|
| Options Outstanding at October 31, 2020 |
|
|
4,346,661 |
|
|
$ |
3.69 |
|
|
|
|
|
| Granted |
|
|
4,490,000 |
|
|
$ |
3.82 |
|
|
|
|
|
| Exercised |
|
|
(33,888 |
) |
|
$ |
3.81 |
|
|
|
|
|
| Expired |
|
|
(1,392,781 |
) |
|
$ |
3.70 |
|
|
|
|
|
| Options Outstanding at October 31, 2021 |
|
|
7,409,992 |
|
|
$ |
3.76 |
|
|
|
|
|
| Granted |
|
|
1,430,000 |
|
|
$ |
2.74 |
|
|
|
|
|
| Exercised |
|
|
(22,620 |
) |
|
$ |
3.15 |
|
|
|
|
|
| Options Outstanding at October 31, 2022 |
|
|
8,817,372 |
|
|
$ |
3.60 |
|
|
$ |
17,644,000 |
|
| Options Exercisable at October 31, 2022 |
|
|
5,219,039 |
|
|
$ |
3.57 |
|
|
$ |
10,331,000 |
|
|
| SCHEDULE OF OUTSTANDING AND EXERCISABLE |
The
following table summarizes information about stock options outstanding under the 2018 Share Plan as of October 31, 2022:
SCHEDULE
OF OUTSTANDING AND EXERCISABLE
| |
|
|
Options Outstanding |
|
|
Options Exercisable |
|
Range of
Exercise Prices |
|
|
Number Outstanding
|
|
|
Weighted Average Remaining Contractual Life (in
years)
|
|
|
Weighted Average Exercise
Price
|
|
|
Number Exercisable
|
|
|
Weighted Average Remaining Contractual Life (in
years)
|
|
|
Weighted Average Exercise
Price
|
|
| $ |
2.09-$3.87
|
|
|
|
5,347,372 |
|
|
|
7.41 |
|
|
$ |
3.24 |
|
|
|
3,927,095 |
|
|
|
6.85 |
|
|
$ |
3.40 |
|
| $ |
3.96-$5.30
|
|
|
|
3,470,000 |
|
|
|
7.98 |
|
|
$ |
4.16 |
|
|
|
1,291,944 |
|
|
|
7.07 |
|
|
$ |
4.09 |
|
|
| Common Stock Warrant [Member] |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| SCHEDULE OF OUTSTANDING AND EXERCISABLE |
The
following table summarizes information about the Company’s outstanding and exercisable warrants as of October 31, 2022:
SCHEDULE
OF OUTSTANDING AND EXERCISABLE
|
Range of Exercise
Prices
|
|
|
Number Outstanding and Exercisable
|
|
|
Weighted Average Remaining Contractual Life (in
years)
|
|
|
Weighted Average Exercise
Price
|
|
| $ |
6.56 |
|
|
|
300,000 |
|
|
|
3.39 |
|
|
$ |
6.56 |
|
|